Published in Mol Immunol on December 01, 2015
The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction. Immunity (2016) 1.26
Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia. Cancer Immunol Res (2016) 0.78
Perspective: The Potential Role of Essential Amino Acids and the Mechanistic Target of Rapamycin Complex 1 (mTORC1) Pathway in the Pathogenesis of Child Stunting. Adv Nutr (2016) 0.77
Filling the Tank: Keeping Antitumor T Cells Metabolically Fit for the Long Haul. Cancer Immunol Res (2016) 0.75
Cutting Edge: Murine Mast Cells Rapidly Modulate Metabolic Pathways Essential for Distinct Effector Functions. J Immunol (2016) 0.75
Metabolic Reprogramming in the Tumour Microenvironment: a Hallmark Shared by Cancer Cells and T Lymphocytes. Immunology (2017) 0.75
On the origin of cancer cells. Science (1956) 49.55
Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science (1995) 16.19
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity (1995) 14.90
T cell exhaustion. Nat Immunol (2011) 11.08
Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature (1993) 9.81
CTLA-4 can function as a negative regulator of T cell activation. Immunity (1994) 9.80
Enhancing CD8 T-cell memory by modulating fatty acid metabolism. Nature (2009) 8.09
Cancer's molecular sweet tooth and the Warburg effect. Cancer Res (2006) 7.24
T cell anergy. Annu Rev Immunol (2001) 7.15
The CD28 signaling pathway regulates glucose metabolism. Immunity (2002) 6.65
Redefining chronic viral infection. Cell (2009) 6.30
Posttranscriptional control of T cell effector function by aerobic glycolysis. Cell (2013) 6.30
CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol (2005) 6.18
Isolation of a protein target of the FKBP12-rapamycin complex in mammalian cells. J Biol Chem (1995) 5.57
Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J Exp Med (1987) 5.48
Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development. Immunity (2011) 5.43
Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell (2015) 5.10
Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell (2002) 5.06
Transcriptional mechanisms underlying lymphocyte tolerance. Cell (2002) 4.04
Immunopharmacology of rapamycin. Annu Rev Immunol (1996) 3.86
Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol (2005) 3.74
Fueling immunity: insights into metabolism and lymphocyte function. Science (2013) 3.62
Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Mol Biol Cell (2007) 3.54
The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism. Immunity (2010) 2.85
FK 506: an immunosuppressant for the 1990s? Lancet (1991) 2.80
PD-1 signaling in primary T cells. Immunol Rev (2009) 2.66
Memory CD8(+) T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development. Immunity (2014) 2.63
Genetic basis of viral persistence: single amino acid change in the viral glycoprotein affects ability of lymphocytic choriomeningitis virus to persist in adult mice. J Exp Med (1990) 2.59
Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. Eur J Immunol (2003) 2.31
IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival. Blood (2007) 2.24
Anergic T cells are metabolically anergic. J Immunol (2009) 2.12
Integrating canonical and metabolic signalling programmes in the regulation of T cell responses. Nat Rev Immunol (2014) 1.96
The transcription factor NFAT promotes exhaustion of activated CD8⁺ T cells. Immunity (2015) 1.94
Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. II. Relative importance of glycolysis and oxidative phosphorylation on phytohaemagglutinin stimulation. Exp Cell Res (1973) 1.87
The CD28 and CTLA-4 receptors associate with the serine/threonine phosphatase PP2A. Immunity (2000) 1.74
Overcoming T cell exhaustion in infection and cancer. Trends Immunol (2015) 1.72
Molecular regulation of effector and memory T cell differentiation. Nat Immunol (2014) 1.70
gamma(c) cytokines provide multiple homeostatic signals to naive CD4(+) T cells. Eur J Immunol (2007) 1.55
Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling. Curr Opin Immunol (2004) 1.47
Molecular regulation of interleukin-2 expression by CD28 co-stimulation and anergy. Immunol Rev (1998) 1.43
The T-cell receptor regulates Akt (protein kinase B) via a pathway involving Rac1 and phosphatidylinositide 3-kinase. Mol Cell Biol (2000) 1.40
The transcription factor FoxO1 sustains expression of the inhibitory receptor PD-1 and survival of antiviral CD8(+) T cells during chronic infection. Immunity (2014) 1.40
PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat Commun (2015) 1.36
Opposing regulation of T cell function by Egr-1/NAB2 and Egr-2/Egr-3. Eur J Immunol (2008) 1.35
mTOR signaling in cellular and organismal energetics. Curr Opin Cell Biol (2014) 1.32
Interleukin-3-mediated cell survival signals include phosphatidylinositol 3-kinase-dependent translocation of the glucose transporter GLUT1 to the cell surface. J Biol Chem (2003) 1.31
Transcriptional complexes formed by NFAT dimers regulate the induction of T cell tolerance. J Exp Med (2009) 1.24
Protein kinase B (Akt) regulation and function in T lymphocytes. Semin Immunol (2002) 1.21
Immune exhaustion: driving virus-specific CD8+ T cells to death. Trends Microbiol (1993) 1.20
The inducible expression of the tumor suppressor gene PTEN promotes apoptosis and decreases cell size by inhibiting the PI3K/Akt pathway in Jurkat T cells. Cell Growth Differ (2002) 1.20
Sirolimus (rapamycin): from the soil of Easter Island to a bright future. J Am Acad Dermatol (2007) 1.18
Fatty acid metabolism in the regulation of T cell function. Trends Immunol (2015) 1.01
Mitochondrial and cellular mechanisms for managing lipid excess. Front Physiol (2014) 1.00
FK-506 and cyclosporin A: immunosuppressive mechanism of action and beyond. Curr Opin Immunol (1992) 0.94
Insight into the role of mTOR and metabolism in T cells reveals new potential approaches to preventing graft rejection. Curr Opin Organ Transplant (2014) 0.89
Environmental and metabolic sensors that control T cell biology. Front Immunol (2015) 0.89
Friends not foes: CTLA-4 blockade and mTOR inhibition cooperate during CD8+ T cell priming to promote memory formation and metabolic readiness. J Immunol (2015) 0.84
mTOR signaling and transcriptional regulation in T lymphocytes. Transcription (2014) 0.78
Cellular metabolism modulation in T lymphocyte immunity. Immunology (2014) 0.78
The mechanism of action of cyclosporine: a perspective for the 90's. Clin Biochem (1991) 0.77